Last updated 2026-07-27
TL;DR
No validated enclomiphene dosage calculator exists because dosing depends on baseline labs, not body weight or a formula. Compounded enclomiphene is typically dosed 6.25mg to 25mg daily, adjusted from bloodwork drawn 4-6 weeks after starting. This article explains why calculators for this drug are unreliable and what actually determines your dose.
Is there a real enclomiphene dosage calculator?
Not one that means anything clinically. You can find widgets online that ask for your weight or your starting testosterone and spit out a milligram number, but nothing about enclomiphene dosing scales that way. Enclomiphene is not dosed by body weight like a lot of injectable hormones are. It's dosed by response, meaning your prescriber checks labs, looks at how you're feeling, and adjusts from there. The reason a calculator can't replace that process is simple: enclomiphene works by blocking estrogen receptors at the hypothalamus, which tricks your brain into thinking estrogen is low and ramps up GnRH, then LH and FSH, then testosterone production in the testes. That feedback loop doesn't respond in a straight line to dose. Some men see a big LH bump on 6.25mg. Others need 25mg to move the needle. There's no equation that predicts which one you are before you've actually tried it and drawn blood. What this page gives you instead is the real dosing range used in clinical practice and compounding pharmacy protocols, the logic behind titration, and the lab work that actually functions as your calculator. If you want the full breakdown of standard starting doses, see Enclomiphene Direct dosage.
What is the typical enclomiphene dosage range?
| 6.25mg daily | Conservative starting dose, common when baseline LH is already low-normal | |
|---|---|---|
| 12.5mg daily | Most common starting dose in compounding practice | |
| 25mg daily | Upper range, used when 12.5mg doesn't move testosterone or LH enough | |
| Every-other-day 12.5-25mg | Alternative schedule some prescribers use to reduce estrogen-receptor blockade exposure | Because it's compounded, doses are not standardized between pharmacies the way an FDA-approved tablet strength would be. One compounding pharmacy's 12.5mg capsule and another's should be formulated to the same labeled strength, but filler, base, and capsule consistency can vary. That's part of why sourcing from a provider-reviewed pharmacy relationship matters more with enclomiphene than it would with a mass-produced generic. |
Most compounded enclomiphene protocols fall between 6.25mg and 25mg per day, taken orally, usually in the morning. Some prescribers use every-other-day dosing instead of daily. There is no FDA-approved dose because there is no FDA-approved enclomiphene product on the market right now; every dose you'll see cited comes from compounding pharmacy practice patterns or from the clinical trial program that never reached approval. That trial program is worth knowing about. Enclomiphene citrate was developed under the brand name Androxal by Repros Therapeutics, and it went through Phase 3 trials for secondary hypogonadism. Doses studied were generally 12.5mg and 25mg daily [1]. The FDA never approved it. Repros discontinued the program after failing to reach agreement with the FDA on the trial design needed for approval, and the company was later acquired by Allergan in 2018, which did not pursue enclomiphene further [2]. So the 12.5mg and 25mg figures you'll see everywhere trace back to that abandoned trial, not to an approved label. Here's the honest range breakdown: | Dose | Common use case |
Why can't a calculator use my weight or age to set the dose?
Because enclomiphene's target isn't body mass, it's a receptor feedback loop, and that loop's sensitivity varies by person for reasons body weight doesn't capture. Two men who both weigh 200 pounds can have completely different baseline LH, different degrees of hypothalamic sensitivity to estrogen, and different SHBG levels, all of which change how a given dose translates into a testosterone number. Compare that to something like acetaminophen dosing, where mg/kg genuinely predicts blood levels and effect. Enclomiphene doesn't behave that way. The clinical literature on enclomiphene versus clomiphene citrate (which is a mix of enclomiphene and zuclomiphene isomers) actually shows individual variability is one of the persistent open questions researchers point to, not something a fixed formula resolves [3]. Age matters a little, mostly because baseline testicular function and LH/FSH sensitivity shift with age, but it's not a multiplier you can plug into a formula. What actually predicts your dose need is your own baseline hormone panel and how you respond to the first dose tried. That's why every legitimate protocol says the same thing: start low, test, adjust.
What labs actually determine the right dose (the real 'calculator')
Your bloodwork is the calculator. Baseline panels typically include total testosterone, free testosterone, LH, FSH, and estradiol, drawn before starting and then again 4 to 6 weeks after starting or after any dose change. Some prescribers also check SHBG and a semen analysis if fertility preservation is the specific goal. The logic works like this. If your follow-up total testosterone is still below your target range and LH hasn't risen meaningfully, the dose is probably too low and can be titrated up. If testosterone has overshot into supraphysiologic territory or estradiol has climbed uncomfortably high, the dose usually gets pulled back. If LH and FSH have risen well and testosterone has landed in a comfortable range without new symptoms, you stay put. This is genuinely a slower process than starting exogenous TRT, where the injectable dose more directly and predictably raises serum testosterone. With enclomiphene you're leaning on an intact hypothalamic-pituitary-gonadal axis to respond, and that takes a few weeks to read clearly on labs. Rushing dose increases before you've seen a full lab cycle is a common mistake, and it makes it hard to tell what actually caused a change.
How does enclomiphene dosing compare to TRT and clomiphene?
Enclomiphene dosing is measured in milligrams per day taken orally; TRT is dosed by milligrams per injection, per week, and clomiphene is dosed similarly to enclomiphene but as the racemic mixture. The comparison matters because it explains why enclomiphene doesn't suppress fertility the way exogenous testosterone does. TRT (testosterone cypionate, enanthate, or gel/pellet forms) delivers testosterone directly into the bloodstream. That directly suppresses the hypothalamic-pituitary-gonadal axis: your brain senses plenty of testosterone already circulating, so it stops sending LH and FSH signals to the testes. Sperm production depends on intratesticular testosterone driven by those signals, and exogenous TRT can reduce sperm counts substantially, in some men down to azoospermia, which is well documented in male contraception trial data using injectable testosterone [4]. Enclomiphene doesn't add testosterone from outside. It blocks estrogen's negative feedback signal at the hypothalamus, which increases the body's own LH and FSH output, which in turn raises endogenous testosterone production and, because LH is still stimulating the testes, tends to preserve testicular size and spermatogenesis better than exogenous TRT does [3]. This is the central, evidence-backed reason men interested in fertility look at enclomiphene instead of TRT. It is not a guarantee that fertility is fully preserved in every case, and it does not treat existing fertility problems unrelated to low LH; it just avoids the direct testicular shutdown mechanism that testosterone injections cause. Clomiphene citrate, the older and more widely studied drug, is a mixture of two isomers: enclomiphene (the trans-isomer) and zuclomiphene (the cis-isomer). Enclomiphene is thought to be the isomer responsible for most of the anti-estrogenic, LH-raising effect, while zuclomiphene has a much longer half-life and weaker, estrogen-agonist-like properties that some researchers believe contribute to side effects like mood changes [3] [5]. Isolating enclomiphene alone was the whole premise behind the Androxal development program, the idea being cleaner effect with fewer zuclomiphene-related side effects. That premise was never confirmed through an approved product, and compounded enclomiphene today is sold on the strength of that theory plus off-label clinical use, not an FDA-reviewed efficacy finding. For dosing schedule mechanics, see how Enclomiphene Direct cycle length affects when you'd expect to see stable labs, and check Enclomiphene Direct half life if you're trying to understand why once-daily dosing works pharmacokinetically.
How is compounded enclomiphene actually taken, day to day?
Compounded enclomiphene is almost always an oral capsule taken once daily, usually in the morning with or without food depending on the compounding pharmacy's instructions. It is not injected. This surprises some readers coming from a TRT background where injection technique, needle gauge, and rotating injection sites are a big part of the routine; none of that applies here. If your specific formulation does arrive as a compounded solution or troche rather than a capsule, follow the reconstitution and measuring instructions from your pharmacy exactly, since concentration can vary batch to batch with compounded products. General guidance on reconstituting compounded peptide and hormone products is covered in how to reconstitute Enclomiphene Direct, though most enclomiphene prescriptions do arrive ready to take as a capsule. Consistency in timing matters more than exact clock precision. Taking it around the same time each morning keeps your exposure pattern steady, which matters for interpreting labs drawn at a consistent number of hours post-dose.
Is enclomiphene FDA-approved, and does that affect dosing guidance?
No. Enclomiphene citrate is not FDA-approved as a standalone medication. The Androxal development program by Repros Therapeutics ran Phase 3 trials for secondary hypogonadism but never secured approval, and the company was acquired by Allergan in 2018 without further development of the drug [2]. Everything sold today under the name enclomiphene is a compounded product, prepared by a licensed compounding pharmacy under a prescription, not a mass-manufactured, FDA-approved tablet with an FDA-reviewed dosing label. That has two practical effects on dosing. First, there's no official package insert with an FDA-set dose range to defer to; the 12.5mg-25mg figures used across the industry come from the discontinued trial data and from compounding pharmacy convention, not an approved label [1]. Second, compounded products are regulated differently than approved drugs. Under U.S. law, compounding pharmacies operate under sections 503A or 503B of the Food, Drug, and Cosmetic Act, which permit compounding for individual patients under a prescription but do not require the FDA efficacy and safety review that approved drugs go through [6]. That doesn't mean compounded enclomiphene is unsafe or unregulated; compounding pharmacies are licensed and inspected. It means the dosing guidance you get is built on clinical judgment and off-label trial data, not an FDA-approved label, so working with a prescriber who actually reviews your labs matters more here than with a standard approved generic.
How long before I know if my dose is working?
Plan on 4 to 6 weeks before your first meaningful follow-up labs, and expect the full picture to take 8 to 12 weeks if a dose adjustment is needed after that first check. Testosterone and LH can start moving within the first couple of weeks, but a single early lab draw is not enough to judge a dose because levels can fluctuate and the axis needs time to reach a new steady state. Symptom changes, energy, libido, mood, often lag or lead the lab numbers in ways that don't perfectly track together, which is exactly why prescribers use both self-reported symptoms and objective labs rather than either alone. If you feel great at week 2 but your week-5 labs show testosterone barely above baseline, that's useful information, not a contradiction to ignore. Men using enclomiphene specifically for fertility preservation while trying to conceive should also factor in that a full spermatogenesis cycle in humans takes roughly 64 to 74 days from spermatogonia to mature sperm [7], so semen parameter changes lag hormonal changes by two to three months. Anyone actively trying to conceive should be doing this under a physician monitoring both hormone panels and semen analysis, not adjusting dose based on how they feel.
What side effects should make me question my dose?
Visual disturbances, significant mood changes, and notably elevated estradiol on labs are the main flags that a dose is too high or that enclomiphene isn't the right fit. Visual side effects are a known class effect of SERMs including clomiphene and, less commonly, enclomiphene; any new visual symptom warrants stopping and calling your prescriber, not waiting it out [5]. Headaches, mild nausea, and some mood variability in the first couple of weeks are reported but usually mild and often settle as the body adjusts. Persistent or worsening symptoms are a reason to have your prescriber re-check labs and consider a lower dose or a different approach entirely rather than pushing through. Because enclomiphene raises LH and thus stimulates the testes' own estrogen (aromatase) production along with testosterone, some men do see estradiol rise meaningfully on higher doses. That's a lab-driven adjustment conversation, not something to guess at from symptoms alone.
Who should not try to dose enclomiphene without close monitoring?
Men with a history of blood clots, active liver disease, or a hormone-sensitive condition need a real conversation with a prescriber before starting, not a generic calculator answer. Men whose low testosterone is due to primary testicular failure rather than a hypothalamic-pituitary signaling problem are also poor candidates, since enclomiphene works by increasing LH/FSH signal to testes that need to be capable of responding; if the testes themselves aren't functioning, raising LH doesn't help. This is really the underlying reason a calculator can't stand in for a diagnosis. Before dosing even becomes the question, a prescriber needs to confirm the low testosterone is secondary (hypothalamic/pituitary-driven) rather than primary, using baseline LH and FSH alongside total and free testosterone. Getting that diagnosis wrong means no dose of enclomiphene will fix the underlying problem.
Frequently asked questions
What is the standard starting dose of enclomiphene?
Most compounding pharmacy protocols start men at 12.5mg daily, though some prescribers start conservatively at 6.25mg, especially if baseline LH is already borderline low-normal. There's no FDA-approved starting dose since enclomiphene isn't an approved drug; 12.5mg comes from discontinued Androxal trial data and widespread compounding practice, not an approved label.
Is there an online enclomiphene dosage calculator I can trust?
No validated one exists, and you should be skeptical of any that asks only for weight or age. Enclomiphene dosing depends on baseline LH, FSH, testosterone, and how your individual hypothalamic-pituitary axis responds, which only bloodwork and a prescriber's judgment over several weeks can determine.
How is enclomiphene different from clomiphene?
Clomiphene citrate is a mixture of two isomers: enclomiphene (trans-isomer) and zuclomiphene (cis-isomer). Enclomiphene alone is thought to drive most of the LH-raising, anti-estrogenic effect, while zuclomiphene has a longer half-life and is linked to more of clomiphene's mood-related side effects. Isolating enclomiphene was the idea behind the discontinued Androxal drug program.
Does enclomiphene preserve fertility better than TRT?
It tends to, because it raises LH and FSH rather than replacing testosterone directly, which keeps the testes' own stimulation intact. Exogenous TRT suppresses LH/FSH and can significantly reduce sperm production. This isn't a guarantee of preserved fertility in every man, just a different mechanism with a better fertility-preservation profile in the evidence available so far.
Is enclomiphene FDA-approved?
No. It was developed as Androxal by Repros Therapeutics, completed Phase 3 trials for secondary hypogonadism, but never reached FDA approval. Repros was acquired by Allergan in 2018 without further pursuing it. What's sold today is compounded by licensed pharmacies under prescription, not sold as an approved, mass-manufactured drug.
How often do I need bloodwork while on enclomiphene?
Typically baseline labs before starting, then a follow-up 4 to 6 weeks after starting or after any dose change. Ongoing monitoring every 3 to 6 months is common once a stable dose is found, though your prescriber may adjust this based on your results and goals.
Can I take enclomiphene every other day instead of daily?
Some prescribers do use every-other-day dosing at 12.5mg to 25mg, particularly to manage estradiol response or side effects. It's a legitimate alternative schedule, but it should be set by your prescriber based on your labs, not chosen on your own.
What happens if my dose is too high?
Estradiol can climb, and some men experience mood changes, headaches, or in rare SERM-class cases visual disturbances. Testosterone can also overshoot into a range that isn't necessarily beneficial and complicates interpreting whether the dose is actually helping symptoms. Labs after 4-6 weeks are how you and your prescriber catch this.
How long does it take enclomiphene to raise testosterone?
Some men see LH and testosterone increases within 1-2 weeks, but reliable, stable lab readings usually take 4-6 weeks. If you're tracking fertility markers specifically, expect changes in semen parameters to lag by 2-3 months given the roughly 64-74 day human spermatogenesis cycle.
Why can't my weight determine my enclomiphene dose the way it does for other drugs?
Enclomiphene's effect depends on hypothalamic estrogen-receptor sensitivity and existing LH/FSH signaling, not on distributing a drug through body mass. Two men of identical weight can have very different baseline hormone profiles, so dosing is set by lab response, not a weight-based formula.
Is compounded enclomiphene regulated at all?
Yes, but differently than an FDA-approved drug. Compounding pharmacies operate under sections 503A or 503B of the Food, Drug, and Cosmetic Act, which allow patient-specific compounding under licensed pharmacy oversight without requiring the FDA efficacy review that approved drugs undergo.
Should I adjust my own dose based on how I feel?
No. Symptom changes and lab changes don't always move together, and self-adjusting without labs makes it hard to know if a dose change actually helped or just coincided with normal variation. Any dose change should follow a lab-informed conversation with your prescriber.
Sources
- ClinicalTrials.gov, Androxal (enclomiphene citrate) Phase 3 trial record: Phase 3 trials of enclomiphene (Androxal) for secondary hypogonadism studied 12.5mg and 25mg daily doses
- U.S. Securities and Exchange Commission, EDGAR filing index for Repros Therapeutics Inc.: Repros Therapeutics, developer of Androxal (enclomiphene), was acquired by Allergan in 2018 without further development of the drug
- PubMed, Kim et al., 'Enclomiphene citrate for the treatment of secondary hypogonadism': Clomiphene citrate is a mixture of enclomiphene and zuclomiphene isomers with differing pharmacologic effects and individual patient response variability
- PubMed, World Health Organization Task Force, 'Contraceptive efficacy of testosterone-induced azoospermia in normal men': Exogenous testosterone administration suppresses LH/FSH and can substantially reduce or eliminate sperm production
- FDA label information, clomiphene citrate prescribing information (historical reference): Visual disturbances are a documented class effect associated with SERM drugs including clomiphene citrate
- U.S. Food and Drug Administration, Compounding and the FDA: Compounding pharmacies operate under sections 503A and 503B of the Food, Drug, and Cosmetic Act, distinct from FDA drug approval requirements
- StatPearls (NCBI Bookshelf), 'Physiology, Spermatogenesis': A full human spermatogenesis cycle takes approximately 64 to 74 days